These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19874851)

  • 21. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J; Mwethera PG; Hussey GD; Wiysonge CS
    BMC Infect Dis; 2012 Nov; 12():289. PubMed ID: 23130761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual transmission of HIV-1.
    Fox J; Fidler S
    Antiviral Res; 2010 Jan; 85(1):276-85. PubMed ID: 19874852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbicides to prevent heterosexual transmission of HIV: ten years down the road.
    van de Wijgert J; Coggins C
    BETA; 2002; 15(2):23-8. PubMed ID: 12064303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. siRNA-based topical microbicides targeting sexually transmitted infections.
    Katakowski JA; Palliser D
    Curr Opin Mol Ther; 2010 Apr; 12(2):192-202. PubMed ID: 20373263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand.
    Newman PA; Roungprakhon S; Tepjan S
    J Int AIDS Soc; 2013 Aug; 16(1):18476. PubMed ID: 23911116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral-based HIV prevention strategies for women.
    Chirenje ZM; Marrazzo J; Parikh UM
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1177-86. PubMed ID: 20954882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-based HIV-1 microbicides.
    Dey B; Lagenaur LA; Lusso P
    Curr HIV Res; 2013 Oct; 11(7):576-94. PubMed ID: 24382025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
    Turpin JA
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1077-97. PubMed ID: 12150703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.
    Barouch DH; Klasse PJ; Dufour J; Veazey RS; Moore JP
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8694-8. PubMed ID: 22586094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
    mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
    Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides.
    Keller MJ; Herold BC
    Sex Transm Dis; 2009 Mar; 36(3 Suppl):S92-5. PubMed ID: 19218889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microbicides for preventing sexually transmitted infections: Current status and strategies for preclinical evaluation of new candidates].
    Fernández Romero JA; Gil PI; Ré V; Robbiani M; Paglini G
    Rev Argent Microbiol; 2014; 46(3):256-68. PubMed ID: 25444135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attaining realistic and substantial reductions in HIV incidence: model projections of combining microbicide and male circumcision interventions in rural Uganda.
    Cox AP; Foss AM; Shafer LA; Nsubuga RN; Vickerman P; Hayes RJ; Watts C; White RG
    Sex Transm Infect; 2011 Dec; 87(7):635-9. PubMed ID: 21768615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.